Cargando…
Reply to SGLT-2 inhibitors: Post-infarction interventional effects
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023432/ https://www.ncbi.nlm.nih.gov/pubmed/36642618 http://dx.doi.org/10.1016/j.phrs.2023.106664 |
| _version_ | 1784908898695643136 |
|---|---|
| author | Paolisso, Pasquale Bergamaschi, Luca Gragnano, Felice Gallinoro, Emanuele Cesaro, Arturo Sardu, Celestino Mileva, Niya Foà, Alberto Armillotta, Matteo Sansonetti, Angelo Amicone, Sara Impellizzeri, Andrea Esposito, Giuseppe Morici, Nuccia Andrea, Oreglia Jacopo Casella, Gianni Mauro, Ciro Vassilev, Dobrin Galie, Nazzareno Santulli, Gaetano Marfella, Raffaele Calabrò, Paolo Barbato, Emanuele Pizzi, Carmine |
| author_facet | Paolisso, Pasquale Bergamaschi, Luca Gragnano, Felice Gallinoro, Emanuele Cesaro, Arturo Sardu, Celestino Mileva, Niya Foà, Alberto Armillotta, Matteo Sansonetti, Angelo Amicone, Sara Impellizzeri, Andrea Esposito, Giuseppe Morici, Nuccia Andrea, Oreglia Jacopo Casella, Gianni Mauro, Ciro Vassilev, Dobrin Galie, Nazzareno Santulli, Gaetano Marfella, Raffaele Calabrò, Paolo Barbato, Emanuele Pizzi, Carmine |
| author_sort | Paolisso, Pasquale |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10023432 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100234322023-03-18 Reply to SGLT-2 inhibitors: Post-infarction interventional effects Paolisso, Pasquale Bergamaschi, Luca Gragnano, Felice Gallinoro, Emanuele Cesaro, Arturo Sardu, Celestino Mileva, Niya Foà, Alberto Armillotta, Matteo Sansonetti, Angelo Amicone, Sara Impellizzeri, Andrea Esposito, Giuseppe Morici, Nuccia Andrea, Oreglia Jacopo Casella, Gianni Mauro, Ciro Vassilev, Dobrin Galie, Nazzareno Santulli, Gaetano Marfella, Raffaele Calabrò, Paolo Barbato, Emanuele Pizzi, Carmine Pharmacol Res Article 2023-03 2023-01-13 /pmc/articles/PMC10023432/ /pubmed/36642618 http://dx.doi.org/10.1016/j.phrs.2023.106664 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
| spellingShingle | Article Paolisso, Pasquale Bergamaschi, Luca Gragnano, Felice Gallinoro, Emanuele Cesaro, Arturo Sardu, Celestino Mileva, Niya Foà, Alberto Armillotta, Matteo Sansonetti, Angelo Amicone, Sara Impellizzeri, Andrea Esposito, Giuseppe Morici, Nuccia Andrea, Oreglia Jacopo Casella, Gianni Mauro, Ciro Vassilev, Dobrin Galie, Nazzareno Santulli, Gaetano Marfella, Raffaele Calabrò, Paolo Barbato, Emanuele Pizzi, Carmine Reply to SGLT-2 inhibitors: Post-infarction interventional effects |
| title | Reply to SGLT-2 inhibitors: Post-infarction interventional effects |
| title_full | Reply to SGLT-2 inhibitors: Post-infarction interventional effects |
| title_fullStr | Reply to SGLT-2 inhibitors: Post-infarction interventional effects |
| title_full_unstemmed | Reply to SGLT-2 inhibitors: Post-infarction interventional effects |
| title_short | Reply to SGLT-2 inhibitors: Post-infarction interventional effects |
| title_sort | reply to sglt-2 inhibitors: post-infarction interventional effects |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023432/ https://www.ncbi.nlm.nih.gov/pubmed/36642618 http://dx.doi.org/10.1016/j.phrs.2023.106664 |
| work_keys_str_mv | AT paolissopasquale replytosglt2inhibitorspostinfarctioninterventionaleffects AT bergamaschiluca replytosglt2inhibitorspostinfarctioninterventionaleffects AT gragnanofelice replytosglt2inhibitorspostinfarctioninterventionaleffects AT gallinoroemanuele replytosglt2inhibitorspostinfarctioninterventionaleffects AT cesaroarturo replytosglt2inhibitorspostinfarctioninterventionaleffects AT sarducelestino replytosglt2inhibitorspostinfarctioninterventionaleffects AT milevaniya replytosglt2inhibitorspostinfarctioninterventionaleffects AT foaalberto replytosglt2inhibitorspostinfarctioninterventionaleffects AT armillottamatteo replytosglt2inhibitorspostinfarctioninterventionaleffects AT sansonettiangelo replytosglt2inhibitorspostinfarctioninterventionaleffects AT amiconesara replytosglt2inhibitorspostinfarctioninterventionaleffects AT impellizzeriandrea replytosglt2inhibitorspostinfarctioninterventionaleffects AT espositogiuseppe replytosglt2inhibitorspostinfarctioninterventionaleffects AT moricinuccia replytosglt2inhibitorspostinfarctioninterventionaleffects AT andreaoregliajacopo replytosglt2inhibitorspostinfarctioninterventionaleffects AT casellagianni replytosglt2inhibitorspostinfarctioninterventionaleffects AT maurociro replytosglt2inhibitorspostinfarctioninterventionaleffects AT vassilevdobrin replytosglt2inhibitorspostinfarctioninterventionaleffects AT galienazzareno replytosglt2inhibitorspostinfarctioninterventionaleffects AT santulligaetano replytosglt2inhibitorspostinfarctioninterventionaleffects AT marfellaraffaele replytosglt2inhibitorspostinfarctioninterventionaleffects AT calabropaolo replytosglt2inhibitorspostinfarctioninterventionaleffects AT barbatoemanuele replytosglt2inhibitorspostinfarctioninterventionaleffects AT pizzicarmine replytosglt2inhibitorspostinfarctioninterventionaleffects |